Targeting Heat-Shock-Protein 90 (Hsp90) by Natural Products: Geldanamycin, a Show Case in Cancer Therapy

Natural Product Reports - United Kingdom
doi 10.1039/c3np70012g
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Royal Society of Chemistry (RSC)

Related search

Heat Shock Protein 90 (HSP90AA1; Hsp90)

Science-Business eXchange
2009English

Heat Shock Protein 90 (HSP90) and Her2 in Adenocarcinomas of the Esophagus

Cancers
Cancer ResearchOncology
2014English

B-Cell CLL/lymphoma 6 (BCL6); Heat Shock Protein 90 (Hsp90)

Science-Business eXchange
2009English

Inhibition of Heat Shock Protein 70 and 90 (Hsp70 and Hsp90) in Target Spesific Cancer Treatment

Advanced Techniques in Biology & Medicine
2015English

Myeloid-Lymphoid or Mixed-Lineage Leukemia (MLL; HRX); Heat Shock Protein 90 (Hsp90)

Science-Business eXchange
2014English

Abrogation of Heat Shock Protein 70 Induction as a Strategy to Increase Antileukemia Activity of Heat Shock Protein 90 Inhibitor 17-Allylamino-Demethoxy Geldanamycin

Cancer Research
Cancer ResearchOncology
2005English

Interaction of Vanadate Oligomers and Permolybdate With the 90-kDa Heat-Shock Protein, Hsp90

FEBS Journal
BiochemistryCell BiologyMolecular Biology
1998English

Crowding Activates Heat Shock Protein 90

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Targeting Heat Shock Protein 90 With CUDC-305 Overcomes Erlotinib Resistance in Non-Small Cell Lung Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy